Molecular Genetic Medicine (eBook)
246 Seiten
Elsevier Science (Verlag)
978-1-4832-6187-4 (ISBN)
The book opens with a chapter on the history of the molecular approach to the thalassemias, among the most common and severe of all human genetic diseases. Separate chapters follow covering the history and current state of the fragile X syndrome; the mechanisms of hepatitis B viral gene expression, its relation to liver cancer, and its prevention; and molecular genetics of Down syndrome. Subsequent chapters deal with mammalian X chromosome inactivation; the use of the human hprt locus as a model system for analyzing mutation in human cells in vivo; and the regulatory genes and factors that govern virus replication of HIV-1.
Molecular Genetic Medicine, Volume II, summarizes progress in several of the most important areas of modern molecular genetics and medicine. The chapters deal with ancient and common genetic diseases, a new infectious disease that threatens to become a world-wide scourge for all of humanity, and two of the most important and still poorly understood causes of mental retardation. The common thread winding through these separate stories is the astounding illumination of all these disorders by modern molecular genetic studies. The book opens with a chapter on the history of the molecular approach to the thalassemias, among the most common and severe of all human genetic diseases. Separate chapters follow covering the history and current state of the fragile X syndrome; the mechanisms of hepatitis B viral gene expression, its relation to liver cancer, and its prevention; and molecular genetics of Down syndrome. Subsequent chapters deal with mammalian X chromosome inactivation; the use of the human hprt locus as a model system for analyzing mutation in human cells in vivo; and the regulatory genes and factors that govern virus replication of HIV-1.
Front Cover 1
Molecular Genetic Medicine 4
Copyright Page 5
Table of Contents 6
Contributors 10
Preface 12
Chapter 1.
16
I. DISEASES OF HEMOGLOBIN 16
II. GLOBIN GENE ORGANIZATION 17
III. CONTROL OF GLOBIN GENE EXPRESSION 20
IV. THALASSEMIAS 31
V. HEMOGLOBINOPATHIES 36
VI. ANALYSIS OF GLOBIN GENE FUNCTION 38
VII. SWITCHING 40
VIII. GENE THERAPY 42
Acknowledgments 45
References 45
Chapter 2.
54
I. INTRODUCTION 54
II. HISTORY OF THE FRAGILE X SYNDROME 55
III. EPIDEMIOLOGY OF FRAGILE X SYNDROME 56
IV. FEATURES OF AFFECTED AND TRANSMITTING MALES 57
V. THE ASSOCIATION OF FRAGILE X AND AUTISM 61
VI. CARRIER FEMALES 62
VII. CYTOGENETICS OF THE FRAGILE X SYNDROME 62
VIII. TREATMENT 64
IX. PRENATAL DIAGNOSIS 65
X. DNA MOLECULAR MARKERS 65
XI. THEORIES REGARDING THE NATURE OF THE fra(X) MUTATION 71
XII. APPROACHES TO DEFINE THE NATURE OF THE MUTATION 72
XIII. CONCLUSIONS 74
References 75
Chapter 3.
82
I. OVERVIEW OF THE PROBLEM 82
II. DISCOVERY OF THE VIRUS 83
III. GENETIC ORGANIZATION OF THE HBV GENOME 87
IV. VIRAL MORPHOGENESIS 91
V. HEPATOCELLULAR CARCINOMA 98
VI. FUTURE PROSPECTS, OPPORTUNITIES, AND CHALLENGES 107
References 108
Chapter 4. The Molecular Genetics of Down Syndrome 120
I. INTRODUCTION 120
II. GENE DOSAGE EFFECTS 121
III. MOLECULAR DEFINITION OF THE DS REGION OF HSA-21 125
IV. ANIMAL MODELS OF DOWN SYNDROME 127
V. SUMMARY 132
Acknowledgments 132
References 132
Chapter 5. Mammalian X Chromosome Inactivation 136
I. INTRODUCTION 136
II. INITIATION OF X INACTIVATION 141
III. SPREADING OF THE X INACTIVATION SIGNAL 148
IV. MAINTENANCE OF X INACTIVATION 152
V. PERSPECTIVES 164
Acknowledgments 165
References 165
Chapter 6. Molecular Analysis of Mutation in the Human Gene for Hypoxanthine Phosphoribosyltransferase 176
I. INTRODUCTION 176
II. THE HPRT ENZYME AND CLINICAL FEATURES OF HPRT DEFICIENCY 177
III. LOCALIZATION, STRUCTURE, AND EXPRESSION OF THE hprt GENE 179
IV. GERM-LINE MUTATIONS IN HPRT-DEFICIENT PATIENTS 182
V. SOMATIC hprt MUTATIONS 186
VI. CONSIDERATIONS ABOUT THE SOMATIC AND GERM-LINE MUTATIONAL SPECTRA IN THE HUMAN hprt GENE 193
References 200
Chapter 7. Regulatory Genes of Human Immunodeficiency Viruses 204
I. INTRODUCTION 204
II. RETROVIRUS LIFE CYCLE 205
III. COUPLING OF VIRUS REPLICATION TO CELL CYCLE AND ACTIVATION 206
IV. HIV REGULATORY GENES 209
V. THE Tat TRANS-ACTIVATION PATHWAY 209
VI. EXPANDED REPERTOIRE OF Tat ACTIVITIES 217
VII. THE Rev TRANS-ACTIVATION PATHWAY 219
VIII. VIRAL PROTEINS 222
IX. CONCLUSIONS 227
References 227
Index 236
Erscheint lt. Verlag | 22.10.2013 |
---|---|
Sprache | englisch |
Themenwelt | Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik |
Studium ► 2. Studienabschnitt (Klinik) ► Pathologie | |
Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
Naturwissenschaften ► Biologie ► Humanbiologie | |
Naturwissenschaften ► Chemie | |
Sozialwissenschaften ► Ethnologie | |
Sozialwissenschaften ► Soziologie | |
Technik | |
ISBN-10 | 1-4832-6187-5 / 1483261875 |
ISBN-13 | 978-1-4832-6187-4 / 9781483261874 |
Haben Sie eine Frage zum Produkt? |
![PDF](/img/icon_pdf_big.jpg)
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich